HCTI to serve as U.S. technology and capital-markets partner, bringing AI, cloud and data expertise as ARCB and Kanzun launch cross-border healthcare investment platform

PLEASANTON, Calif., Sept. 17, 2026 /PRNewswire/ — Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a U.S.-based healthcare technology company, today announced that it has signed on as the U.S. technology and capital-markets partner for a new fund built to move Malaysian healthcare companies to the world stage. The Kanzun-ARCB Growth Fund launched through a Memorandum of Understanding signed in Kuala Lumpur, Malaysia, pairing Dubai-based ARCB Investment LLC’s (“ARCB”) capital network with Kanzun Ventures Management Sdn. Bhd.’s (“Kanzun”) deal experience on the ground in Malaysia. HCTI’s role will be to get qualifying companies ready, technologically and financially, for a successful run at the U.S. capital markets.

ARCB brings roughly AED 300 million in assets under management and a network of family offices, institutional investors and strategic partners across the Middle East and Asia. The firm opened its Asia-Pacific office in Kuala Lumpur in April 2026, and the Kanzun-ARCB Growth Fund marks its first major platform launch in the region. Together with Kanzun and HCTI, the three parties are building a structured corridor connecting Malaysian healthcare companies to Middle Eastern capital and, from there, to U.S. capital markets.

How the Partnership Will Work

Kanzun will lead the deal sourcing, due diligence, valuation and portfolio development in Malaysia, identifying healthcare companies with real growth potential. ARCB anchors the fund’s capital formation, drawing on its investor network across the Middle East and Asia. HCTI steps in once a target companies are ready for thier next stage of growth. The Company applies its Nasdaq-listed experience and its expertise in artificial intelligence, cloud, data and digital infrastructure to help build the technology foundation and market readiness a U.S. expansion requires.

Management’s Comments

Dr Suresh Venkatachari, Founder and Head of M&A of Healthcare Triangle, Inc., said: “We are pleased to collaborate with ARCB and Kanzun Ventures in evaluating opportunities within the Malaysian AI and healthcare sector. We look forward to supporting qualifying companies in their AI technology transformation and evaluating appropriate strategic pathways to expand in U.S. markets.”

Dr Chaskar U., Chief Executive Officer of ARCB Group, said: “Since establishing our ASEAN presence in Kuala Lumpur this April, we have been deliberate about where and how ARCB deploys capital in this region. Malaysia’s healthcare sector is full of founders who have built genuinely strong businesses but have not yet had access to the institutional capital, governance and international positioning needed to compete globally. That is precisely the gap ARCB exists to close. With Kanzun’s execution capability on the ground and Healthcare Triangle’s technology and U.S. market experience, we are building more than a fund — we are building a corridor that connects Malaysian healthcare champions to Middle Eastern capital and, from there, to the U.S. capital markets. This is what our ASEAN strategy was always designed to deliver.”

Mr Loganathan S., Chief Executive Officer of Kanzun Ventures Management Sdn. Bhd., said: “Malaysia has healthcare entrepreneurs who have spent many years building strong businesses, but many of these companies remain relatively small from an international capital-market perspective. Working with ARCB gives us access to an international capital network, while our collaboration with Healthcare Triangle provides an important connection to healthcare technology and the U.S. market.”

About Healthcare Triangle, Inc.

Healthcare Triangle, Inc. (Nasdaq: HCTI), based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. The Company supports healthcare organizations — including hospitals and health systems, payers, and pharma/life sciences organizations — in their effort to improve health outcomes through better utilization of the data and information technologies they rely on. Healthcare Triangle’s Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™, has achieved HITRUST Risk-based, 2-year (r2) Certified status, demonstrating to clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical and business performance optimization.

About ARCB Investment LLC

ARCB Investment LLC is a UAE fund house established in 2022 and a Mainland investment management licensed company (License No. 1041252), under the leadership of Chairman His Excellency Dr Mohammed Saeed Al Kindi, a former UAE Minister and diplomat, and Chief Executive Officer Dr Chaskar U. ARCB manages assets under management of approximately AED 300 million across ten sectors, including energy, water, healthcare, education, agriculture, industry, tourism, sports, technology and commercial real estate. ARCB is a participant of the United Nations Global Compact.

About Kanzun Ventures Management Sdn. Bhd.

Kanzun Ventures Management Sdn. Bhd. is a Malaysia-based venture capital management corporation registered with the Securities Commission Malaysia. Kanzun focuses on identifying, structuring and developing investment opportunities with the potential for significant growth and strategic value, including opportunities across healthcare and healthcare-related industries.

Forward-Looking Statements and Safe Harbor Notice

This press release contains forward-looking statements concerning the proposed collaboration among Healthcare Triangle, Inc., ARCB Investment LLC and Kanzun Ventures Management Sdn. Bhd., including statements regarding potential investments, acquisitions, capital raising, technology integration, strategic transactions and potential U.S. capital-market opportunities for Malaysian healthcare companies. References to targeted healthcare companies or segments in this announcement should not be interpreted as confirmation that any acquisition, investment, consolidation or U.S. listing has been completed. Any proposed transaction remains subject to due diligence, audit, valuation, negotiations, corporate and regulatory approvals, financing and the execution of definitive agreements. Nothing contained in this announcement constitutes an offer to sell or a solicitation of an offer to purchase securities or interests in any fund, company or investment vehicle. Any reference to Nasdaq or the U.S. capital markets represents a strategic objective or potential pathway only and does not constitute a representation or guarantee that any company will be listed on Nasdaq or complete any U.S. capital-market transaction.

All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as “projected,” “expect,” “possibility” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties, and assumptions, including market and other conditions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors outlined in the Company’s annual report on Form 10-K for the year ended December 31, 2025, on file with the Securities and Exchange Commission (the “SEC”) and in previous filings, subsequent filings and future periodic reports filed with the SEC. All the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

Investor Contact

Healthcare Triangle, Inc.
1-800-617-9550
ir@healthcaretriangle.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/healthcare-triangle-nasdaq-hcti-joins-kanzun-arcb-growth-fund-to-build-malaysia-to-us-corridor-for-ai-and-healthcare-companies-302882548.html

SOURCE Healthcare Triangle, Inc.